SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

DALPIAZ, Alessandro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.374
AS - Asia 7.409
EU - Europa 4.334
SA - Sud America 1.320
AF - Africa 113
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 8
AN - Antartide 1
Totale 27.575
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.109
SG - Singapore 2.940
CN - Cina 2.102
BR - Brasile 1.096
UA - Ucraina 986
HK - Hong Kong 766
DE - Germania 708
IT - Italia 690
TR - Turchia 568
GB - Regno Unito 487
VN - Vietnam 395
SE - Svezia 297
FI - Finlandia 276
RU - Federazione Russa 241
PL - Polonia 227
IN - India 173
FR - Francia 142
MX - Messico 133
CA - Canada 110
ID - Indonesia 88
AR - Argentina 87
JP - Giappone 67
NL - Olanda 57
ZA - Sudafrica 50
BD - Bangladesh 48
PK - Pakistan 41
AT - Austria 38
CO - Colombia 38
EC - Ecuador 37
ES - Italia 36
LT - Lituania 35
IR - Iran 33
IQ - Iraq 32
CZ - Repubblica Ceca 27
TW - Taiwan 27
BE - Belgio 24
PY - Paraguay 23
EG - Egitto 20
CL - Cile 17
KR - Corea 17
UZ - Uzbekistan 17
AE - Emirati Arabi Uniti 12
SA - Arabia Saudita 12
TH - Thailandia 11
KE - Kenya 10
IE - Irlanda 9
VE - Venezuela 9
AU - Australia 8
MA - Marocco 8
NZ - Nuova Zelanda 8
DO - Repubblica Dominicana 7
NP - Nepal 7
RO - Romania 7
DZ - Algeria 6
PE - Perù 6
PH - Filippine 6
AL - Albania 5
AZ - Azerbaigian 5
BG - Bulgaria 5
CH - Svizzera 5
HU - Ungheria 5
IL - Israele 5
JO - Giordania 5
PS - Palestinian Territory 5
TN - Tunisia 5
CR - Costa Rica 4
DK - Danimarca 4
ET - Etiopia 4
PT - Portogallo 4
BA - Bosnia-Erzegovina 3
BO - Bolivia 3
EU - Europa 3
GR - Grecia 3
HN - Honduras 3
KZ - Kazakistan 3
LB - Libano 3
MK - Macedonia 3
MY - Malesia 3
RS - Serbia 3
SC - Seychelles 3
SY - Repubblica araba siriana 3
XK - ???statistics.table.value.countryCode.XK??? 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
GE - Georgia 2
GY - Guiana 2
JM - Giamaica 2
KG - Kirghizistan 2
NO - Norvegia 2
OM - Oman 2
QA - Qatar 2
SN - Senegal 2
UY - Uruguay 2
AQ - Antartide 1
BB - Barbados 1
BH - Bahrain 1
BS - Bahamas 1
CG - Congo 1
DM - Dominica 1
Totale 27.561
Salva come PNG Salva come JPEG
Città #
Singapore 1.637
Woodbridge 1.461
Fairfield 1.339
Ashburn 1.190
Jacksonville 1.016
Houston 1.008
Chandler 855
Hong Kong 759
Santa Clara 756
Beijing 667
Ann Arbor 622
Wilmington 558
Seattle 534
Cambridge 480
Izmir 338
Nanjing 297
Princeton 227
Warsaw 218
Ferrara 214
Boardman 188
Dallas 180
New York 180
Los Angeles 175
Ho Chi Minh City 140
San Diego 120
The Dalles 119
Munich 115
Milan 114
Addison 104
Hanoi 103
Nanchang 99
São Paulo 87
Mexico City 84
Shenyang 81
Hefei 77
Hebei 74
Shanghai 71
Tianjin 64
Jakarta 58
London 55
Changsha 54
Brooklyn 49
Falls Church 49
Rio de Janeiro 48
Bremen 47
Chicago 47
Helsinki 47
Redwood City 46
San Mateo 46
Tokyo 45
Dearborn 44
Moscow 43
Turku 38
Montreal 36
Jiaxing 35
Buffalo 34
Falkenstein 34
Kunming 34
Frankfurt am Main 33
Norwalk 33
Denver 28
Mountain View 28
Jinan 27
Stockholm 27
Belo Horizonte 26
Johannesburg 26
Toronto 26
Atlanta 25
Ankara 24
Boston 23
Chennai 23
Orem 23
Poplar 23
Zhengzhou 23
Phoenix 22
San Francisco 22
Vienna 22
Bologna 21
Philadelphia 21
Amsterdam 20
Brussels 20
Manchester 19
Porto Alegre 19
Auburn Hills 18
Columbus 18
Guangzhou 18
Ningbo 18
Nuremberg 18
Washington 18
Olomouc 16
Rome 16
Salt Lake City 16
Tappahannock 16
Verona 16
Curitiba 15
Düsseldorf 15
Mumbai 15
Tashkent 15
Asunción 14
Brasília 14
Totale 18.120
Salva come PNG Salva come JPEG
Nome #
C- and N-terminal residue effect on peptide derivatives' antagonism toward the formyl-peptide receptor 316
Indomethacin co-crystals and their parent mixtures: does the intestinal barrier recognize them differently? 255
Application of the “in-oil nanoprecipitation” method in the encapsulation of hydrophilic drugs in PLGA nanoparticles 246
Nose-to-brain delivery of antiviral drugs: A way to overcome their active efflux? 231
Geraniol pharmacokinetics, bioavailability and its multiple effects on the liver antioxidant and xenobiotic-metabolizing enzymes 215
Brain targeting of resveratrol by nasal administration of chitosan-coated lipid microparticles 213
A novel hybrid drug between two potent anti-tubulin agents as a potential prolonged anticancer approach 212
Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity 205
Conjugation of aspirin with vitamin C: uptake and stability studies 205
Ascorbic and 6-Br-ascorbic acid conjugates as a tool to increase the therapeutic effects of potentially central active drugs 200
Development and characterization of biodegradable nanospheres as delivery systems of anti-ischemic adenosine derivatives. 192
Design, synthesis and activity of ascorbic acid prodrugs of nipecotic, kynurenic and diclophenamic acids, liable to increase neurotropic activity 189
Design, synthesis and in vitro evaluation on HRPE cells of ascorbic and 6-bromoascorbic acid conjugates with neuroactive molecules 189
Binding thermodynamics and intrinsic activity of adenosine A1 receptor ligands 187
Physicochemical stability of cabazitaxel and docetaxel solutions 186
Receptor binding thermodynamics as a tool for linking drug efficacy and affinity 184
A concerted binding study using binding measurements, X-ray structural data and molecular modeling on the stereochemical features responsible for the affinity of 6-arylpyrrolo[2,1-d][1,5]benzothiazepines to mitochondrial benzodiazepine receptors 181
Responses of peripheral blood mononucleated cells from non-celiac gluten sensitive patients to various cereal sources 177
Transporter-mediated effects of diclofenamic acid and its ascorbyl pro-drug in the in vivo neurotropic activity of ascorbyl nipecotic acid conjugate 176
Brain Targeting of an Antiischemic Agent by Nasal Administration of Microparticles 176
Allosteric modulation, thermodynamics and binding to wild-type and mutant (T277A) adenosine A 1 receptors of LUF5831, a novel nonadenosine-like agonist 174
Bile salt-coating modulates the macrophage uptake of nanocores constituted by a zidovudine prodrug and enhances its nose-to-brain delivery 174
Binding thermodynamics at A1 and A2A adenosine receptors 173
Met-Ile-Phe-Leu derivatives: full and partial agonists of human neutrophil formylpeptide receptors 171
Expression and characterization of vitamin C transporter in the human trophoblast cell line HTR-8/SVneo: Effect of steroids, flavonoids and NSAIDs 170
Brain uptake of a Zidovudine prodrug after nasal administration of solid lipid microparticles 170
Development and characterization of PLGA nanoparticles as delivery systems of a prodrug of zidovudine obtained by its conjugation with ursodeoxycholic acid 168
Conformational Aspects of Human Formyl-peptide Receptor Agonists 167
Nasal chitosan microparticles target a zidovudine prodrug to brain HIV sanctuaries 167
Phe-D-Leu-Phe-D-Leu-Phe derivatives as formylpeptide receptor antagonists in human neutrophils: cellular and conformational aspects 166
1H-pyrazolo[4,3-d]pyrimidine-7(6H)-one and 5H-pyrazolo[4,3-d] 1,2,3-triazin-4(3H)-one derivatives. Synthesis and in vitro biological activity at adenosine A1 and A2a receptors 163
From Physical Mixtures to Co-Crystals: How the Coformers Can Modify Solubility and Biological Activity of Carbamazepine 162
Dopamine-sensitive adenylyl cyclases in neuronal development: Physiopathological and pharmacological implications 160
Solid lipid microparticles for the stability enhancement of a dopamine prodrug 159
Binding thermodynamics of 5-HT(1A) receptor ligands 159
Characterisation of potential adenosine A1 receptor prodrugs of adenosine derivatives with antiischemic properties 158
Conformational aspects of human formylpeptide receptor antagonists 157
An RPE cell line as a useful in vitro model for studying retinoic acid receptor beta: expression and affinity. 156
Uptake in the Central Nervous System of Geraniol Oil Encapsulated in Chitosan Oleate Following Nasal and Oral Administration 154
[3H] CGS 21680 binding to purified adenosine A2A receptors in human platelets 153
Binding therodynamics and intrinsic activity of adenosine A1 receptor ligands: a model of their heart rate inhibition power. 152
Vitamin C and 6-amino-vitamin C conjugates of diclofenac: synthesis and evaluation 152
Exploring the use of spray congealing to produce solid dispersions with enhanced indomethacin bioavailability: In vitro characterization and in vivo study 152
Solid microparticles based on chitosan or methyl-beta-cyclodextrin: A first formulative approach to increase the nose-to-brain transport of deferoxamine mesylate 152
Molecular mechanism involved in the transport of a prodrug dopamine glycosyl conjugate 149
Synthesis and biological evaluation of pro-drugs of GW196771, a potent glycine antagonist acting at the NMDA receptor 149
Controlled release studies of antiischemic agents encapsulated in poly(lactic acid) nanoparticles. 149
Oxcarbazepine free or loaded PLGA nanoparticles as effective intranasal approach to control epileptic seizures in rodents 148
Brain targeting of neuroactive drugs: studies of their transport mechanisms as conjugated with vitamin C or glucose. 147
Progress in drug delivery to the central nervous system by the prodrug approach 147
Binding thermodynamics of adenosine A2a receptor ligands 147
Poly(lactic acid) microspheres for the sustained release of antiischemic agents 145
Can pharmaceutical co-crystals provide an opportunity to modify the biological properties of drugs? 144
Complementary use of flow and sedimentation field-flow fractionation techniques for size characterizing biodegradable poly(lactic acid) nanospheres 143
Incorporation of the polar antiischemic drug N6-cyclopentyladenosine in solid lipid microparticles 143
[3H] SCH 58261 labels adenosine A2A receptors in human lymphocyte membranes 143
Polymeric nanoparticles as drug controlled release systems: a new formulation strategy for drugs with small or large molecular weight 142
N-ureido peptide derivatives as antagonists towar human neutrophil formylpeptide receptor 141
Peptide derivatives as agonists or antagonists of formylpeptide receptors: analysis of their effects on neutrophils 140
Cationic liposomes carrying anti herpetic peptides as potential ocular vaccine 139
Exploring the Use of Spray Congealing to Produce Solid Dispersions with Enhanced Indomethacin Bioavailability 139
Studies on human neutrophil biological functions by means of formylpeptide receptor agonists and antagonists 138
Adenosine analogs prodrugs: design, synthesis and chemico-physical characterization of N6-cyclopentyladenosine (CPA) derivatives 137
[3H] CGS 21680 binding to purified adenosine A2A receptors in human platelets 137
Evidence for the presence of N-formyl-methionyl-leucyl-phenylalanine (fMLP) receptor ligands in human amniotic fluid and fMLP receptor modulation by physiological labour 136
Binding thermodynamics as a tool to investigate the mechanisms of drug-receptor interactions: Thermodynamics of cytoplasmic steroid/nuclear receptors in comparison with membrane receptors 136
Full and partial agonists and thermodynamic binding parameters of adenosine A1 receptor ligands 135
Bile acids modulation of nanoparticle macrophage uptake 135
Drug release from pharmaceutical co-crystals: Are therapeutic and safety properties of active pharmaceutical substances retained? 134
Hyaluronic acid based-hybrid nanoparticles for targeted nose- to-brain delivery of dimethyl fumarate 133
Determination of the adenosine A1 agonist N6-cyclopentyladenosine in rat blood by solid-phase extraction and HPLC 133
Thermodynamics of full agonist, partial agonist, and antagonist binding to wild-type and mutant adenosine A1 receptors 133
[3H] SCH 58261 labels adenosine A2A receptors in human lymphocyte membranes 133
Particulate formulations based on chitosan for nose-to-brain delivery of drugs. A review 132
Potential therapeutic effects of odorants through their ectopic receptors in pigmented cells 132
Prodrugs and Endogenous Transporters: Are They Suitable Tools for Drug Targeting into the Central Nervous System? 130
Quantitative determination of zolmitriptan in rat blood and cerebrospinal fluid by reversed phase HPLC-ESI-MS/MS analysis: application to in-vivo preclinical pharmacokinetic study 130
From crystal to solution and across the membranes: the case of carbamazepine co-crystals 130
Adenosine A1 receptor: Analysis of the potential therapeutic effects obtained by its activation in the central nervous system 129
Cancer stem cells and nanomedicine: new opportunities to combat multidrug resistance? 128
Neuroactive molecules and their pro-drugs obtained by conjugation with vitamin c: studies of delivery into the brain. 127
Can Thermodynamic Measurements of Receptor Binding Yield Information on Drug Affinity and Efficacy? 127
Binding thermodynamics and intrinsic activity of adenosine A1 receptor ligands: a model of their heart rate inhibition power. 127
Caffeine intake induces an alteration of human neutrophils A2A adenosine receptors. 127
Nuclear Retinoic Acid Receptor Beta as a Tool in Chemoprevention Trials 127
Temperature dependence and GABA modulation of β-carboline binding to rat cerebellum benzodiazepine receptors 126
Preparation and characterization of starch/cyclodextrin bioadhesive microspheres as platform for nasal administration of Gabexate Mesylate (Foy (R)) in allergic rhinitis treatment 125
Biochemical and pharmacological characterization of periodate-oxidized adenosine analogues at adenosine A1 receptors. 125
Materie Prime: Eccipienti 124
Thermodynamics of 5-HT3 receptor binding discriminates agonistic from antagonistic behaviour 124
Coniugati dell’acido ascorbico ad attività neurotropica. 124
Effect of chronic caffeine intake on A2A adenosine receptors in human neutrophils. 124
Nasal administration and brain targeting of an antiischemic agent 123
Uptake and stability studies of diclofenamic acid and its pro-drug obtained by conjugation with vitamin C 123
Temperature dependence of the affinity enhancement of selective adenosine A1 receptor agonism: A thermodynamic analysis 122
Influence of secondary preparative parameters and aging effects on PLGA particle size distribution: A sedimentation field flow fractionation investigation 122
Characterization of A2A Adenosine Receptors in Human Lymphocyte Membranes by [3H]-SCH 58261 Binding 122
Pharmacological and Biochemical Characterization of Purified A2A Adenosine Receptors in Human Platelet Membranes by [3H]-CGS 21680 Binding 121
Effect of chronic caffeine intake on A2A adenosine receptors in human neutrophils. 120
Binding thermodynamics of serotonin to rat brain 5HT1A, 5HT2A and 5HT3 receptors 119
Totale 15.489
Salva come PNG Salva come JPEG
Categoria #
all - tutte 131.713
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.091
Totale 134.804
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.700 0 0 0 0 0 273 80 298 106 446 366 131
2021/20221.984 50 229 148 121 88 85 77 105 76 164 182 659
2022/20231.979 227 94 53 256 380 308 59 156 250 15 115 66
2023/2024994 121 133 57 24 94 111 35 39 15 19 33 313
2024/20254.803 98 91 382 190 613 431 192 295 726 583 712 490
2025/20266.742 1.245 583 1.173 1.706 1.767 268 0 0 0 0 0 0
Totale 27.890